RESUMO
In this study which was done on 85 cases, NHL reprsented 5.7% of total malignancies and 75% of all lymphomas, the intermediate grade was the most common type [71.8%]. About half of patients had advanced stage [III, IV] disease [49.4%]. Out of the evaluable 80 cases, 39 patients achieved CR, 17 achieved PR and 29 were primary refractory to treatment. Of the 39 cases who achieved CR to treatment, relapse occurred in 56.4% [secondary failure]. The median survival of our patients was 14 months with a survival rate of 17.5% after 3 years and 8.8% after 5 years. These low figures were due to high percentage of intermediate and high grade in relation to low grade cases as well as the relatively high incidence of advanced stages of disease [stage III and IV] which could be explained by the low medical and health awareness and the low socioeconomic status